Hemochromatosis detection in a health screening program at an Alabama forest products mill

Journal of Occupational and Environmental Medicine

Volumn 44, Issue 8, 2002, Pages 745-751

  Barton, James C ^a   Cheatwood, Susan M ^a   Key, Timothy J ^a   Acton, Ronald T ^a  

^a G 105 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGROFORESTRY; ARTICLE; BIOCHEMISTRY; CAUCASIAN; CONCENTRATION RESPONSE; EMPLOYEE; EVALUATION; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NEGRO; OCCUPATIONAL DISEASE; WORKPLACE; BLOOD; MIDDLE AGED; OCCUPATIONAL HEALTH SERVICE; UNITED STATES; WOOD;

PIERINAE;

FERRITIN;

ADULT; ALABAMA; FEMALE; FERRITINS; HEMOCHROMATOSIS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCUPATIONAL HEALTH SERVICES; WOOD; WORKPLACE;

EID: 0036667861     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-200208000-00009     Document Type: Article

References (56)

1. Screening blood donors for hereditary hemochromatosis: Decision analysis model based on a 30-year database
2. A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations
3. Haemochromatosis in Ireland and HFE
4. Population screening for hemochromatosis
5. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: Predictions from a model based on national, racial, and ethnic group composition in central Alabama
6. Practice parameter for hereditary hemochromatosis
7. Screening for hemochromatosis in primary care settings
8. Diagnosis of hemochromatosis
9. Iron overload, public health, and genetics: Evaluating the evidence for hemochromatosis screening
10. Population screening for hemochromatosis. Has the time finally come?
11. Management of hemochromatosis
12. Cost-effectiveness evaluation of screening programs: Hereditary hemochromatosis
13. Cost-effectiveness of screening for hereditary hemochromatosis
14. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers
15. Prevalence of hemochromatosis among 11, 065 presumably healthy blood donors
16. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older
17. Prevalence of hereditary hemochromatosis in 16031 primary care patients
18. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri
19. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic
20. Screening for hemochromatosis: A cost-effectiveness study based on 12, 258 patients
21. Evaluation of a workplace hemochromatosis screening program
22. HEmochromatosis and IRon overload Screening (HEIRS) Study design
23. Hepatic pathology in relatives of patients with hemochromatosis
24. Novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
25. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria
26. Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis
27. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients
28. Hemochromatosis: Gene discovery and its implications for population-based screening
29. HFE mutations analysis in 711 hemochromatosis probands: Evidence for S65C implication in mild form of hemochromatosis
30. Genotyping as a diagnostic aid in genetic haemochromatosis
31. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
32. Diagnosis of hemochromatosis in a community hospital
33. Identification of homozygous hemochromatosis subjects by measurements of hepatic iron index
34. Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations
35. Two novel missense HFE mutations (I105T and G93R) and confirmation of the S65C mutation in Alabama hemochromatosis probands
36. Screening for hemochromatosis and iron deficiency in employees and primary care patients in western Germany
37. Hemochromatosis: Association of severity of iron overload with genetic markers
38. Population screening for hemochromatosis: Expectation on a study of relative of symptomatic probands
39. Screening tests for hemochromatosis
40. Hereditary hemochromatosis
41. Clinical features of genetic hemochromatosis in women compared with men
42. Hemochromatosis: Gene discovery and its implications for population-based screening
43. Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis
44. Heterogeneity of hemochromatosis in Italy
45. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene
46. HFE genotype frequencies in consecutive reference laboratory specimens: Comparisons among referral sources and association with initial diagnosis
47. Mutation analysis in hereditary hemochromatosis
48. Iron overload in African Americans
49. Primary iron overload in African Americans
50. Iron overload in African Americans
51. Inheritance of two HFE mutations in African Americans: Cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency
52. Iron overload in Africa. Interaction between a gene and dietary iron content
53. Distribution of transferrin saturations in the African-American population
54. Histochemically demonstrable hepatic iron excess in African Americans
55. Sickle cell disease and hemochromatosis
56. Prostate cancer screening in a large corporation population